Efficacy of Phosphatidylinositol-3 Kinase Inhibitors in a Primary Mouse Model of Undifferentiated Pleomorphic Sarcoma

Recent advances in sarcoma genomics have identified novel mutations in the PI3K pathway in human sarcomas. Here, we use a mouse model of primary soft-tissue sarcoma for preclinical testing of doxorubicin and inhibitors of the PI3K pathway: BKM120 (PI3K inhibitor) and BEZ235 (a dual PI3K/mTOR inhibit...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Suzy, Dodd, Rebecca D., Mito, Jeffrey K., Ma, Yan, Kim, Yongbaek, Riedel, Richard F., Kirsch, David G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3350993/
https://www.ncbi.nlm.nih.gov/pubmed/22619567
http://dx.doi.org/10.1155/2012/680708

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3350993/
https://www.ncbi.nlm.nih.gov/pubmed/22619567
http://dx.doi.org/10.1155/2012/680708

Ejemplares similares